Microbial conversion and in vitro and in vivo antifungal assessment of bioconverted docosahexaenoic acid (bDHA) used against agricultural plant pathogenic fungi.
Microbial modification of polyunsaturated fatty acids can often lead to special changes in their structure and in biological potential. Therefore, the aim of this study was to develop potential antifungal agents through the microbial conversion of docosahexaenoic acid (DHA). Bioconverted oil extract of docosahexaenoic acid (bDHA), obtained from the microbial conversion of docosahexaenoic acid (DHA) by Pseudomonas aeruginosa PR3, was assessed for its in vitro and in vivo antifungal potential. Mycelial growth inhibition of test plant pathogens, such as Botrytis cinerea, Colletotrichum capsici, Fusarium oxysporum, Fusarium solani, Phytophthora capsici, Rhizoctonia solani and Sclerotinia sclerotiorum, was measured in vitro. bDHA (5 microl disc(-1)) inhibited 55.30-65.90% fungal mycelium radial growth of all the tested plant pathogens. Minimum inhibitory concentrations (MICs) of bDHA against the tested plant pathogens were found in the range of 125-500 microg ml(-1). Also, bDHA had a strong detrimental effect on spore germination for all the tested plant pathogens. Further, three plant pathogenic fungi, namely C. capsici, F. oxysporum and P. capsici, were subjected to an in vivo antifungal screening. bDHA at higher concentrations revealed a promising antifungal effect in vivo as compared to the positive control oligochitosan. Furthermore, elaborative study of GC-MS analysis was conducted on bioconverted oil extract of DHA to identify the transformation products present in bDHA. The results of this study indicate that the oil extract of bDHA has potential value of industrial significance to control plant pathogenic fungi.
Bajpai
Vivek K
VK
Department of Biotechnology, Daegu University, Kyoungsan, Kyoungbook, Republic of Korea.
Kim
Hak Ryul
HR
Hou
Ching Tsang
CT
Kang
Sun Chul
SC
D000935:Antifungal Agents / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D001711:Biotransformation; D004281:Docosahexaenoic Acids / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D005658:Fungi / Q000187:drug effects* / Q000254:growth & development; D010935:Plant Diseases / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000737:chemistry / Q000378:metabolism*; D013172:Spores, Fungal / Q000187:drug effects / Q000502:physiology
D000935:Antifungal Agents; D004281:Docosahexaenoic Acids